The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lysenko A.V.

Petrovsky Russian Scientific Center of Surgery

Salagaev G.I.

Petrovsky Russian Scientific Center of Surgery

Lednev P.V.

Petrovsky Russian Scientific Center of Surgery

Dzeranova A.N.

Petrovsky National Research Center of Surgery

Belov Yu.V.

Petrovsky National Research Center of Surgery;
Sechenov First Moscow State Medical University

Mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy

Authors:

Lysenko A.V., Salagaev G.I., Lednev P.V., Dzeranova A.N., Belov Yu.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2023;(10): 7‑13

Read: 1810 times


To cite this article:

Lysenko AV, Salagaev GI, Lednev PV, Dzeranova AN, Belov YuV. Mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy. Pirogov Russian Journal of Surgery. 2023;(10):7‑13. (In Russ.)
https://doi.org/10.17116/hirurgia20231017

Recommended articles:
Surgical treatment of patients with functional mitral regu­rgitation and aortic valve disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):310-325
Redo mitral valve replacement for dysfunction of mitral bioprosthesis. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):490-492
Posterior left ventricular wall rupture following mitral valve replacement. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):598-601
Redo surgical treatment of a patient with recu­rrent symptoms of obstructive hype­rtrophic cardiomyopathy. Russian Journal of Cardiology and Cardiovascular Surgery. 2026;(1):98-101

References:

  1. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232-2239.
  2. Uematsu S, Takaghi A, Imamura Y, Ashihara K, Hagiwara N. Clinical features of the systolic anterior motion of the mitral valve among patients without hypertrophic cardiomyopathy. J Cardiol. 2017;69:495-500. 
  3. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Manage-ment of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733-2779.
  4. Yu EH, Omran AS, Wigle ED, Williams WG, Siu SC, Rakowski H. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol. 2000;36:2219-2225.
  5. Ferrazzi P, Spirito P, Iacovoni A, Calabrese A, Migliorati K, Simon C, et al. Transaortic chordal cutting: mitral valve repair for obstructive hypertrophic cardiomyopathy with mild septal hypertrophy. J Am Coll Cardiol. 2015;66:1687-1696.
  6. Rowin EJ, Maron BJ, Lesser JR, Rastegar H, Maron MS. Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management. Am J Cardiol. 2013;111:1677-1679.
  7. Cooley DA, Wukasch DC, Leachman RD. Mitral valve replacement for idiopathic hypertrophic subaortic stenosis. Results in 27 patients. J Cardiovasc Surg (Torino). 1976;17:380-387. 
  8. Fighali S, Krajcer Z, Leachman RD. Septal myomectomy and mitral valve replacement for idiopathic hypertrophic subaortic stenosis: short- and long-term follow-up. J Am Coll Cardiol. 1984;3:1127-1134.
  9. Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anoma-lous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg. 2004;127:481-489. 
  10. Wang S, Cui H, Yu Q, Chen H, Zhu C, Wang J, et al. Excision of anomalous muscle bundles as an important addition to extended septal myectomy for treatment of left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg. 2016;152:461-168. 
  11. Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG. The mitral valve in obstructive hypertrophic cardiomyopathy: a test in context. J Am Coll Cardiol. 2016;67:1846-1858.
  12. Krajcer Z, Leachman RD, Cooley DA, Ostojic M, Coronado R. Mitral valve replacement and septal myomectomy in hypertrophic cardiomyopathy. Ten- year follow-up in 80 patients. Circulation. 1988;78:35-43. 
  13. Minakata K, Dearani JA, Schaff HV, O’Leary PW, Ommen SR, Danielson GK. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 2005;80:851-856. 
  14. Takahashi J, Wakamatsu Y, Okude J, Gohda T, Sanefuji Y, Kanaoka T, et al. Septal myectomy, papillary muscle resection, and mitral valve replacement for hypertrophic obstructive cardiomyopathy: a case report. Ann Thorac Cardio-vasc Surg. 2008;14:258-262. 
  15. Hong JH, Schaff HV, Nishimura RA, Abel MD, Dearani JA, Li Z, et al. Mitral regurgitation in patients with hypertrophic obstructive cardiomyopathy: implications for concomitant valve procedures. J Am Coll Cardiol. 2016;68:1497-1504.
  16. Spirito P, Iascone M, Ferrazzi P. Mitral valve abnormalities in hypertrophic cardiomyopathy: a primary expression of the disease? Getting closer to the answer European Heart Journal — Cardiovascular Imaging. 2018;19:1107-1108. https://doi.org/10.1093/ehjci/jey112
  17. Groarke JD, Galazka PZ, Cirino AL, Lakdawala N, Thune JJ, Bundgaard H, et al. Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers. Eur Heart J Cardiovasc Imaging. 2018;19:1109-1116.
  18. Schaff HV, Hong JH, Nishimura RA, Abel MD, Dearani JA, Ommen SR. Reply: To Add or Not to Add Mitral Valve Surgery to Septal Myectomy in HOCM Patients. Journal of the American College of Cardiology. 2017;69(17):2250-2251. https://doi.org/10.1016/j.jacc.2017.01.067
  19. Lysenko AV, Salagaev GI, Lednev PV, Belov YuV. Surgical treatment of a patient with hypertrophic obstructive cardiomyopathy and p.Arg456Gln mutation in the PRKAG2 gene. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2022;15(1):81-84. (In Russ.). https://doi.org/10.17116/kardio20221501181
  20. Lysenko AV, Salagaev GI, Lednev PV, Belov YuV. Surgical treatment of obstructive hypertrophic cardiomyopathy combined with muscle bridging of the left anterior descending artery. Pirogov Russian Journal of Surgery = Khirurgiya. Zurnal im. N.I. Pirogova. 2022;(1):81-83. (In Russ.). https://doi.org/10.17116/hirurgia202201181

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.